Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 1.00 |
| ▸ | MEN1 | O00255 | 6/20 | 1.00 |
| ▸ | HTT | P42858 | 5/20 | 1.00 |
| ▸ | BLM | P54132 | 4/20 | 1.00 |
| ▸ | NPC1 | O15118 | 6/20 | 0.98 |
| ▸ | RAB9A | P51151 | 6/20 | 0.98 |
| ▸ | MAPT | P10636 | 4/20 | 0.98 |
| ▸ | THRB | P10828 | 3/20 | 0.98 |
| ▸ | PKM | P14618 | 3/20 | 0.98 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.98 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.98 |
| ▸ | POLB | P06746 | 2/20 | 0.98 |
| ▸ | RECQL | P46063 | 2/20 | 0.98 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.98 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.98 |
| ▸ | USP2 | O75604 | 2/20 | 0.98 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.98 |
| ▸ | CTNNB1 | P35222 | 2/20 | 0.98 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.98 |
| ▸ | LMNA | P02545 | 1/20 | 0.98 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dithiazanine SCHEMBL10035960 | 1.00 | KMT2A (1.00) | KMT2AMEN1HTTBLMNPC1 | |
| Dithiazanine SCHEMBL17278433 | 1.00 | KMT2A (1.00) | KMT2AMEN1HTTBLMNPC1 | |
| Dithiazanine SCHEMBL1567134 | 1.00 | KMT2A (1.00) | KMT2AMEN1HTTBLMNPC1 | |
| SCHEMBL10110715 | 1.00 | KMT2A (1.00) | KMT2AMEN1HTTBLMNPC1 | |
| SCHEMBL30356388 | 1.00 | KMT2A (1.00) | KMT2AMEN1HTTBLMNPC1 | |
| SCHEMBL1598509 | 1.00 | KMT2A (1.00) | KMT2AMEN1HTTBLMNPC1 | |
| SCHEMBL12868063 | 1.00 | KMT2A (1.00) | KMT2AMEN1HTTBLMNPC1 | |
| Iodide SCHEMBL335663 | 0.99 | MEN1 (1.00) | KMT2AMEN1HTTBLMNPC1 | |
| Dithiazanine SCHEMBL22877 | 0.99 | MEN1 (1.00) | KMT2AMEN1HTTBLMNPC1 | |
| Bromide SCHEMBL11693039 | 0.99 | KMT2A (0.98) | KMT2AMEN1HTTBLMNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024118805-A1 | TOPOISOMERASE III (TOP3) INHIBITORS AND ANTIVIRAL COMPOUNDS BASED ON CYANINES | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-06-06 | — | — | WO | disclosed |
| US-20130209357-A1 | MOLECULAR PROBES FOR IMAGING MYELIN | CASE WESTERN RESERVE UNIVERSITY (US) | 2013-08-15 | — | — | US | disclosed |
| US-7501172-B2 | Integrated recording and labeling with optical recording device | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2009-03-10 | — | — | US | disclosed |
| WO-2008058885-A2 | RADIATION-HARDENABLE COATING MASSES | BASF SE (DE) | 2008-05-22 | — | — | WO | disclosed |
| US-7172991-B2 | Integrated CD/DVD recording and labeling | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2007-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130209357-A1 | MOLECULAR PROBES FOR IMAGING MYELIN | MAG, PMP22, MYT1 | KMT2A 4489/4885MEN1 891/4885HTT 3251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.